Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 1;77(19):5222-5227.
doi: 10.1158/0008-5472.CAN-17-0054. Epub 2017 Sep 19.

New Advances and Challenges of Targeting Cancer Stem Cells

Nurmaa K Dashzeveg  1 , Rokana Taftaf  1 , Erika K Ramos  1 , Luke Torre-Healy  2 , Anastasia Chumakova  2 , Daniel J Silver  2 , Tyler J Alban  2 , Maksim Sinyuk  2 , Praveena S Thiagarajan  2 , Awad M Jarrar  2 , Soumya M Turaga  2 , Caner Saygin  2 , Erin Mulkearns-Hubert  2 , Masahiro Hitomi  2 , Jeremy N Rich  3   4   5 , Stanton L Gerson  4   5   6 , Justin D Lathia  2   4   5 , Huiping Liu  7   4   5   8   9
Affiliations

New Advances and Challenges of Targeting Cancer Stem Cells

Nurmaa K Dashzeveg et al. Cancer Res. .

Abstract

The second International Cancer Stem Cell Conference in Cleveland, Ohio, on September 20-23, 2016, convened 330 attendees from academic, industrial, and clinical organizations. It featured a debate on the concepts and challenges of the cancer stem cells (CSC) as well as CSC-centered scientific sessions on clinical trials, genetics and epigenetics, tumor microenvironment, immune suppression, metastasis, therapeutic resistance, and emerging novel concepts. The conference hosted 35 renowned speakers, 100 posters, 20 short talks, and a preconference workshop. The reported advances of CSC research and therapies fostered new collaborations across national and international borders, and inspired the next generation's young scientists. Cancer Res; 77(19); 5222-7. ©2017 AACR.

PubMed Disclaimer

Conflict of interest statement

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

References

    1. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645–8. - PubMed
    1. Adorno-Cruz V, Kibria G, Liu X, Doherty M, Junk DJ, Guan D, et al. Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance. Cancer Res. 2015;75:924–9. - PMC - PubMed
    1. Ng SW, Mitchell A, Kennedy JA, Chen WC, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540:433–7. - PubMed
    1. Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014;506:328–33. - PMC - PubMed
    1. Guo W, Keckesova Z, Donaher JL, Shibue T, Tischler V, Reinhardt F, et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell. 2012;148:1015–28. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources